Tashanna Myers
Papers
2
Total Citations
34
H-Index
2
About
Dr. Tashanna Myers is a leading gynecologic oncologist whose research centers on surgical innovation in the treatment of gynecologic malignancies, with a particular focus on cervical and endometrial cancers. Her most impactful contribution is the landmark ROCC/GOG-3043 trial, a randomized non-inferiority study comparing robotic versus open radical hysterectomy for early-stage cervical cancer. This pivotal work, which has garnered 24 citations, directly challenges the paradigm shift following the 2018 LACC trial by rigorously evaluating whether robotic surgery can preserve the perioperative benefits of minimally invasive surgery without compromising oncologic outcomes. Dr. Myers also demonstrated clinical ingenuity in a case report (10 citations) detailing the minimally invasive diagnosis and treatment of endometrial cancer following LeFort colpocleisis, establishing a novel protocol for managing a rare and diagnostically challenging presentation. Her work bridges the gap between surgical safety and oncologic efficacy, offering critical evidence to guide surgical decision-making. By addressing both common and rare clinical scenarios, Dr. Myers has advanced the field of gynecologic oncology, providing surgeons with data-driven strategies to optimize patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2